J8 - what is your take on this?
On face value looks good, especially if there were no withdrawals....however with all these things, the devil is in the detail. Hopefully they find someone to buy their compounds.
GLTA
- Forums
- ASX - By Stock
- BIT
- Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial
Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-6
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $1.375K | 72.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1679974 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 80000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 1679974 | 0.019 |
12 | 2341165 | 0.018 |
5 | 688000 | 0.017 |
11 | 1524225 | 0.016 |
4 | 660000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 80000 | 1 |
0.021 | 305547 | 4 |
0.022 | 600000 | 2 |
0.023 | 307000 | 2 |
0.024 | 255035 | 3 |
Last trade - 11.09am 12/11/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online